Skip to main content
Erschienen in: Cardiovascular Toxicology 2/2012

01.06.2012

High-Sensitivity CRP in Opiate Addiction: Relative and Age-Dependent Elevations

verfasst von: Albert Stuart Reece

Erschienen in: Cardiovascular Toxicology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

High-sensitivity C-reactive protein (hs-CRP) has been shown to be linked with immune stimulation, but is not well studied over the lifetime in opiate addiction. hs-CRP was measured by standard laboratory methods in substance use disorder (SUD) patients and non-SUD (NSUD) aged 18–48 years. Data were log transformed to improve normality. 1231 SUD were compared with 326 NSUD patients of comparable ages. hs-CRP was 7.46 ± 14.24 versus 4.75 ± 13.40 mg/l (mean ± SD) significantly higher in the SUD group (P < 0.0001), a difference which persisted after exclusion of acutely elevated hs-CRP values (P < 0.0001). In multiple regression with age, addictive status was significant both by itself (P < 0.0001) and in interaction with age (P < 0.0001). At age 40 years, the SUD group had a mean hs-CRP of 3.68 which the NSUD group did not achieve till a modelled age of 157.09 years. In an interactive multivariate regression, interactions between age, addictive status, ALT and AST were significant. These data show that hs-CRP is elevated in opiate dependence both per se, and when controlled for age. Furthermore, they suggest that hs-CRP and immune stimulation seen in opiate addiction may underlie the acceleration of age-related multi-system chronic and coronary atherosclerotic disease well described in opiate dependence.
Literatur
1.
Zurück zum Zitat Yano, Y., Matsuda, S., Hatakeyama, K., Sato, Y., Imamura, T., Shimada, K., et al. (2010). Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients. The journals of gerontology. Series A, Biological sciences and medical sciences, 65, 547–552.PubMedCrossRef Yano, Y., Matsuda, S., Hatakeyama, K., Sato, Y., Imamura, T., Shimada, K., et al. (2010). Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients. The journals of gerontology. Series A, Biological sciences and medical sciences, 65, 547–552.PubMedCrossRef
2.
Zurück zum Zitat Agrawal, A., Singh, P. P., Bottazzi, B., Garlanda, C., & Mantovani, A. (2009). Pattern recognition by pentraxins. Advances in Experimental Medicine and Biology, 653, 98–116.PubMedCrossRef Agrawal, A., Singh, P. P., Bottazzi, B., Garlanda, C., & Mantovani, A. (2009). Pattern recognition by pentraxins. Advances in Experimental Medicine and Biology, 653, 98–116.PubMedCrossRef
3.
Zurück zum Zitat (2008). Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: The JUPITER study. Cardiovascular Journal of Africa, 19, 332–334, discussion 335. (2008). Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: The JUPITER study. Cardiovascular Journal of Africa, 19, 332–334, discussion 335.
4.
Zurück zum Zitat Slattery, M. L., Curtin, K., Poole, E. M., Duggan, D. J., Samowitz, W. S., Peters, U., et al. (2010). Genetic variation in C-reactive protein (CRP) in relation to colon and rectal cancer risk and survival. International Journal of Cancer, 128, 2726–2734.CrossRef Slattery, M. L., Curtin, K., Poole, E. M., Duggan, D. J., Samowitz, W. S., Peters, U., et al. (2010). Genetic variation in C-reactive protein (CRP) in relation to colon and rectal cancer risk and survival. International Journal of Cancer, 128, 2726–2734.CrossRef
5.
Zurück zum Zitat Chaturvedi, A. K., Caporaso, N. E., Katki, H. A., Wong, H. L., Chatterjee, N., Pine, S. R., et al. (2010). C-Reactive Protein and Risk of Lung Cancer. Journal of Clinical Oncology, 28, 2716–2726.CrossRef Chaturvedi, A. K., Caporaso, N. E., Katki, H. A., Wong, H. L., Chatterjee, N., Pine, S. R., et al. (2010). C-Reactive Protein and Risk of Lung Cancer. Journal of Clinical Oncology, 28, 2716–2726.CrossRef
6.
Zurück zum Zitat Everett, B. M., Glynn, R. J., MacFadyen, J. G., & Ridker, P. M. (2010). Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation, 121, 143–150.PubMedCrossRef Everett, B. M., Glynn, R. J., MacFadyen, J. G., & Ridker, P. M. (2010). Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation, 121, 143–150.PubMedCrossRef
7.
Zurück zum Zitat Antonescu-Turcu, A. L., & Tomic, R. (2009). C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations. Current Opinion in Pulmonary Medicine, 15, 120–125.PubMedCrossRef Antonescu-Turcu, A. L., & Tomic, R. (2009). C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations. Current Opinion in Pulmonary Medicine, 15, 120–125.PubMedCrossRef
8.
Zurück zum Zitat Kalhan, R., Tran, B. T., Colangelo, L. A., Rosenberg, S. R., Liu, K., Thyagarajan, B., et al. (2010). Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS ONE, 5, e11431.PubMedCrossRef Kalhan, R., Tran, B. T., Colangelo, L. A., Rosenberg, S. R., Liu, K., Thyagarajan, B., et al. (2010). Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS ONE, 5, e11431.PubMedCrossRef
9.
Zurück zum Zitat Bafadhel, M., Clark, T. W., Reid, C., Medina, M. J., Batham, S., Barer, M. R., et al. (2010). Procalcitonin and C reactive protein in hospitalised adult patients with community acquired pneumonia, exacerbation of asthma and chronic obstructive pulmonary disease. Chest, 139, 1410–1418.PubMedCrossRef Bafadhel, M., Clark, T. W., Reid, C., Medina, M. J., Batham, S., Barer, M. R., et al. (2010). Procalcitonin and C reactive protein in hospitalised adult patients with community acquired pneumonia, exacerbation of asthma and chronic obstructive pulmonary disease. Chest, 139, 1410–1418.PubMedCrossRef
10.
Zurück zum Zitat Brunton, L. L., Lazo, J. S., & Parker, K. L. (Eds.). (2006). Goodman and gilman’s the pharmacologic basis of therapeutics (11th ed.). New York: McGraw Hill. Brunton, L. L., Lazo, J. S., & Parker, K. L. (Eds.). (2006). Goodman and gilman’s the pharmacologic basis of therapeutics (11th ed.). New York: McGraw Hill.
11.
Zurück zum Zitat McCarthy, L., Wetzel, M., Sliker, J. K., Eisenstein, T. K., & Rogers, T. J. (2001). Opioids, opioid receptors, and the immune response. Drug and Alcohol Dependence, 62, 111–123.PubMedCrossRef McCarthy, L., Wetzel, M., Sliker, J. K., Eisenstein, T. K., & Rogers, T. J. (2001). Opioids, opioid receptors, and the immune response. Drug and Alcohol Dependence, 62, 111–123.PubMedCrossRef
12.
Zurück zum Zitat Neri, S., Bruno, C. M., Pulvirenti, D., Malaguarnera, M., Italiano, C., Mauceri, B., et al. (2005). Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers. Psychopharmacology (Berl), 179, 700–704.CrossRef Neri, S., Bruno, C. M., Pulvirenti, D., Malaguarnera, M., Italiano, C., Mauceri, B., et al. (2005). Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers. Psychopharmacology (Berl), 179, 700–704.CrossRef
13.
Zurück zum Zitat Reece, A. S. (2008). Clinical implications of addiction related immunosuppression. The Journal of Infection, 56, 437–445.PubMedCrossRef Reece, A. S. (2008). Clinical implications of addiction related immunosuppression. The Journal of Infection, 56, 437–445.PubMedCrossRef
14.
Zurück zum Zitat Cabral, G. A. (2006). Drugs of abuse, immune modulation, and AIDS. Journal of Neuroimmune Pharmacology, 1, 280–295.PubMedCrossRef Cabral, G. A. (2006). Drugs of abuse, immune modulation, and AIDS. Journal of Neuroimmune Pharmacology, 1, 280–295.PubMedCrossRef
15.
Zurück zum Zitat Pillai, R., Nair, B. S., & Watson, R. R. (1991). AIDS, drugs of abuse and the immune system: A complex immunotoxicological network. Archives of Toxicology, 65, 609–617.PubMedCrossRef Pillai, R., Nair, B. S., & Watson, R. R. (1991). AIDS, drugs of abuse and the immune system: A complex immunotoxicological network. Archives of Toxicology, 65, 609–617.PubMedCrossRef
16.
Zurück zum Zitat Reece, A. S. (2010). Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing. Medical Hypotheses, in press. Reece, A. S. (2010). Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing. Medical Hypotheses, in press.
17.
Zurück zum Zitat Reece, A. S. (2009). Improved parameters of metabolic glycaemic and immune function and arterial stiffness with naltrexone implant therapy. British Medical Journal Case Reports Published 14/04/09. Reece, A. S. (2009). Improved parameters of metabolic glycaemic and immune function and arterial stiffness with naltrexone implant therapy. British Medical Journal Case Reports Published 14/04/09.
18.
Zurück zum Zitat Reece, A. S. (2007). Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immunity and Ageing, 4, 6–15.PubMedCrossRef Reece, A. S. (2007). Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immunity and Ageing, 4, 6–15.PubMedCrossRef
19.
Zurück zum Zitat Wilson, N. S., Behrens, G. M., Lundie, R. J., Smith, C. M., Waithman, J., Young, L., et al. (2006). Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nature Immunology, 7, 165–172.PubMedCrossRef Wilson, N. S., Behrens, G. M., Lundie, R. J., Smith, C. M., Waithman, J., Young, L., et al. (2006). Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nature Immunology, 7, 165–172.PubMedCrossRef
20.
Zurück zum Zitat Xu, R. H., Remakus, S., Ma, X., Roscoe, F., & Sigal, L. J. (2010). Direct presentation is sufficient for an efficient anti-viral CD8 + T cell response. PLoS Pathogens, 6, e1000768.PubMedCrossRef Xu, R. H., Remakus, S., Ma, X., Roscoe, F., & Sigal, L. J. (2010). Direct presentation is sufficient for an efficient anti-viral CD8 + T cell response. PLoS Pathogens, 6, e1000768.PubMedCrossRef
21.
Zurück zum Zitat Carvalho, F. (2009). How bad is accelerated senescence in consumers of drugs of abuse? Adicciones, 21, 99–104.PubMed Carvalho, F. (2009). How bad is accelerated senescence in consumers of drugs of abuse? Adicciones, 21, 99–104.PubMed
22.
Zurück zum Zitat Sargeant, T. J., Day, D. J., Miller, J. H., & Steel, R. W. (2008). Acute in utero morphine exposure slows G2/M phase transition in radial glial and basal progenitor cells in the dorsal telencephalon of the E15.5 embryonic mouse. The European Journal of Neuroscience, 28, 1060–1067.PubMedCrossRef Sargeant, T. J., Day, D. J., Miller, J. H., & Steel, R. W. (2008). Acute in utero morphine exposure slows G2/M phase transition in radial glial and basal progenitor cells in the dorsal telencephalon of the E15.5 embryonic mouse. The European Journal of Neuroscience, 28, 1060–1067.PubMedCrossRef
23.
Zurück zum Zitat Sargeant, T. J., Miller, J. H., & Day, D. J. (2008). Opioidergic regulation of astroglial/neuronal proliferation: Where are we now? Journal of Neurochemistry, 107, 883–897.PubMed Sargeant, T. J., Miller, J. H., & Day, D. J. (2008). Opioidergic regulation of astroglial/neuronal proliferation: Where are we now? Journal of Neurochemistry, 107, 883–897.PubMed
24.
Zurück zum Zitat Reece, A. S., & Davidson, P. (2007). Deficit of circulating stem–progenitor cells in opiate addiction: A pilot study. Substance Abuse Treatment, Prevention, and Policy, 2, 19–28.PubMedCrossRef Reece, A. S., & Davidson, P. (2007). Deficit of circulating stem–progenitor cells in opiate addiction: A pilot study. Substance Abuse Treatment, Prevention, and Policy, 2, 19–28.PubMedCrossRef
25.
Zurück zum Zitat Gopinath, S. D., & Rando, T. A. (2008). Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell, 7, 590–598.PubMedCrossRef Gopinath, S. D., & Rando, T. A. (2008). Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell, 7, 590–598.PubMedCrossRef
26.
Zurück zum Zitat Cherry, C. M., & Matunis, E. L. (2010). Epigenetic regulation of stem cell maintenance in the Drosophila testis via the nucleosome-remodeling factor NURF. Cell Stem Cell, 6, 557–567.PubMedCrossRef Cherry, C. M., & Matunis, E. L. (2010). Epigenetic regulation of stem cell maintenance in the Drosophila testis via the nucleosome-remodeling factor NURF. Cell Stem Cell, 6, 557–567.PubMedCrossRef
27.
Zurück zum Zitat Kerr, C. L., & Cheng, L. (2010). Multiple, interconvertible states of human pluripotent stem cells. Cell Stem Cell, 6, 497–499.PubMedCrossRef Kerr, C. L., & Cheng, L. (2010). Multiple, interconvertible states of human pluripotent stem cells. Cell Stem Cell, 6, 497–499.PubMedCrossRef
28.
Zurück zum Zitat Makela, J., Koivuniemi, R., Korhonen, L., & Lindholm, D. (2010). Interferon-gamma produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells. PLoS ONE, 5, e11091.PubMedCrossRef Makela, J., Koivuniemi, R., Korhonen, L., & Lindholm, D. (2010). Interferon-gamma produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells. PLoS ONE, 5, e11091.PubMedCrossRef
29.
Zurück zum Zitat Darke, S., Kaye, S., & Duflou, J. (2006). Systemic disease among cases of fatal opioid toxicity. Addiction, 101, 1299–1305.PubMedCrossRef Darke, S., Kaye, S., & Duflou, J. (2006). Systemic disease among cases of fatal opioid toxicity. Addiction, 101, 1299–1305.PubMedCrossRef
30.
Zurück zum Zitat Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L. (2009). Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug and Alcohol Dependence, 105, 9–15.PubMedCrossRef Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L. (2009). Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug and Alcohol Dependence, 105, 9–15.PubMedCrossRef
31.
Zurück zum Zitat Kim, T. W., Alford, D. P., Malabanan, A., Holick, M. F., & Samet, J. H. (2006). Low bone density in patients receiving methadone maintenance treatment. Drug and Alcohol Dependence, 85, 258–262.PubMedCrossRef Kim, T. W., Alford, D. P., Malabanan, A., Holick, M. F., & Samet, J. H. (2006). Low bone density in patients receiving methadone maintenance treatment. Drug and Alcohol Dependence, 85, 258–262.PubMedCrossRef
32.
Zurück zum Zitat Rosen, D., Smith, M. L., & Reynolds, C. F., 3rd. (2008). The prevalence of mental and physical health disorders among older methadone patients. The American Journal of Geriatric Psychiatry, 16, 488–497.PubMedCrossRef Rosen, D., Smith, M. L., & Reynolds, C. F., 3rd. (2008). The prevalence of mental and physical health disorders among older methadone patients. The American Journal of Geriatric Psychiatry, 16, 488–497.PubMedCrossRef
33.
Zurück zum Zitat Sadeghian, S., Darvish, S., Davoodi, G., Salarifar, M., Mahmoodian, M., Fallah, N., et al. (2007). The association of opium with coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation, 14, 715–717.PubMedCrossRef Sadeghian, S., Darvish, S., Davoodi, G., Salarifar, M., Mahmoodian, M., Fallah, N., et al. (2007). The association of opium with coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation, 14, 715–717.PubMedCrossRef
34.
Zurück zum Zitat Smyth, B., Hoffman, V., Fan, J., & Hser, Y. I. (2007). Years of potential life lost among heroin addicts 33 years after treatment. Preventive Medicine, 44, 369–374.PubMedCrossRef Smyth, B., Hoffman, V., Fan, J., & Hser, Y. I. (2007). Years of potential life lost among heroin addicts 33 years after treatment. Preventive Medicine, 44, 369–374.PubMedCrossRef
35.
Zurück zum Zitat Darke, S., Duflou, J., & Torok, M. (2010). The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Drug and Alcohol Dependence, 106, 1–6.PubMedCrossRef Darke, S., Duflou, J., & Torok, M. (2010). The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Drug and Alcohol Dependence, 106, 1–6.PubMedCrossRef
36.
Zurück zum Zitat Reece, A. S. (2007). Dentition of addiction in Queensland: Poor dental status and major contributing drugs. Australian Dental Journal, 52, 144–149.PubMedCrossRef Reece, A. S. (2007). Dentition of addiction in Queensland: Poor dental status and major contributing drugs. Australian Dental Journal, 52, 144–149.PubMedCrossRef
37.
Zurück zum Zitat Reece, A. S. (2007). Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program. Substance Abuse Treatment, Prevention, and Policy, 2, 35–49.PubMedCrossRef Reece, A. S. (2007). Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program. Substance Abuse Treatment, Prevention, and Policy, 2, 35–49.PubMedCrossRef
38.
Zurück zum Zitat Burns, L., Randall, D., Hall, W. D., Law, M., Butler, T., Bell, J., et al. (2009). Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention. Addiction, 104, 1363–1372.PubMedCrossRef Burns, L., Randall, D., Hall, W. D., Law, M., Butler, T., Bell, J., et al. (2009). Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention. Addiction, 104, 1363–1372.PubMedCrossRef
39.
Zurück zum Zitat Gottshcalk L. A., McGuire F. L., Heiser J. F., Dinovo E. C., & Birch, H. (1979). Drug abuse deaths in nine cities: A survey report. (National Institute of Drug Abuse ed., vol. 29, NIDA Research Monograph,. pp. 1–189. Bethesda, Maryland, USA: National Institutes of Health), pp. 1–189. Gottshcalk L. A., McGuire F. L., Heiser J. F., Dinovo E. C., & Birch, H. (1979). Drug abuse deaths in nine cities: A survey report. (National Institute of Drug Abuse ed., vol. 29, NIDA Research Monograph,. pp. 1–189. Bethesda, Maryland, USA: National Institutes of Health), pp. 1–189.
40.
Zurück zum Zitat Hser, Y. I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503–508.PubMedCrossRef Hser, Y. I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503–508.PubMedCrossRef
Metadaten
Titel
High-Sensitivity CRP in Opiate Addiction: Relative and Age-Dependent Elevations
verfasst von
Albert Stuart Reece
Publikationsdatum
01.06.2012
Verlag
Humana Press Inc
Erschienen in
Cardiovascular Toxicology / Ausgabe 2/2012
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-012-9154-2

Weitere Artikel der Ausgabe 2/2012

Cardiovascular Toxicology 2/2012 Zur Ausgabe